Ares Genetics’ combines Next Generation Sequencing (NGS) with ARESdb, the world‘s most comprehensive database on the genetics of antibiotic resistance.
ARESdb contains thousands of whole genome sequenced clinical isolates collected from more than 200 centers globally. ARESdb combines broad resistance profiles with high-quality genetic information and enables pathogen identification with up to >99% accuracy and antibiotic resistance detection with up to more than 98%.
ARESdb covers 30 years of emerging antibiotic resistance to accurately detect AMR.
ARESdb is the world’s largest database of genetic antibiotic resistance markers and predictive AMR panels.
ARESdb combines deep whole-genome sequencing data with antibiotic resistance profiles and is continuously expanded.
Our proprietary digital health platform combines a NGS-based Universal Pathogenome Assay (ARESupa) with a cloud based decision support & reporting system (AREScds) that is sustainably keeping pace with rapidly evolving AMR based on an Artificial Intelligence powered in-vitro diagnostics (IVD) Reference Database (ARESdb).
Most comprehensive, global and continuously updated proprietary knowledgebase on genetic antibiotic resistance marker and their diagnostic relevance.
Semi-automated resistance marker discovery, prioritization and validation engine. AI-informed database expansion from structured and unstructured AMR data to diagnostics markers based on expert-defined evidence levels.
Universal Pathogenome Assay (UPA) for any patient sample.
Secure & HIPAA compliant cloud-based Clinical Decision Support system (CDS) linking AMR markers to treatment response.